Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

598 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity and safety of a fully liquid DTaP-IPV-HB-PRP∼T hexavalent vaccine compared with the standard of care in infants in the Republic of Korea.
Kim YK, Vidor E, Kim HM, Shin SM, Lee KY, Cha SH, Ma SH, Kim DH, Lee J, Park SE, Lee H, Kim JD, Kim KH, Kim KH, Kim JH; A3L31 Study Group. Kim YK, et al. Among authors: cha sh. Vaccine. 2017 Jul 13;35(32):4022-4028. doi: 10.1016/j.vaccine.2017.05.062. Epub 2017 Jun 16. Vaccine. 2017. PMID: 28629923 Clinical Trial. No abstract available.
Varicella and varicella vaccination in South Korea.
Oh SH, Choi EH, Shin SH, Kim YK, Chang JK, Choi KM, Hur JK, Kim KH, Kim JY, Chung EH, Lee SY, Park SE, Cha S, Kim KN, Ma SH, Eun BW, Kim NH, Jo DS, Choi BY, Kim SA. Oh SH, et al. Among authors: cha s. Clin Vaccine Immunol. 2014 May;21(5):762-8. doi: 10.1128/CVI.00645-13. Epub 2014 Mar 26. Clin Vaccine Immunol. 2014. PMID: 24671555 Free PMC article.
Long-term immunogenicity of an initial booster dose of an inactivated, Vero cell culture-derived Japanese encephalitis vaccine (JE-VC) and the safety and immunogenicity of a second JE-VC booster dose in children previously vaccinated with an inactivated, mouse brain-derived Japanese encephalitis vaccine.
Yun KW, Lee HJ, Park JY, Cho HK, Kim YJ, Kim KH, Kim NH, Hong YJ, Kim DH, Kim HM, Cha SH. Yun KW, et al. Among authors: cha sh. Vaccine. 2018 Mar 7;36(11):1398-1404. doi: 10.1016/j.vaccine.2018.01.075. Vaccine. 2018. PMID: 29429815
A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.
Kim DS, Houillon G, Jang GC, Cha SH, Choi SH, Lee J, Kim HM, Kim JH, Kang JH, Kim JH, Kim KH, Kim HS, Bang J, Naimi Z, Bosch-Castells V, Boaz M, Bouckenooghe A. Kim DS, et al. Among authors: cha sh. Hum Vaccin Immunother. 2014;10(9):2656-63. doi: 10.4161/hv.29743. Epub 2014 Nov 6. Hum Vaccin Immunother. 2014. PMID: 25483480 Free PMC article. Clinical Trial.
Immunogenicity and safety assessment of a trivalent, inactivated split influenza vaccine in Korean children: Double-blind, randomized, active-controlled multicenter phase III clinical trial.
Han SB, Rhim JW, Shin HJ, Lee SY, Kim HH, Kim JH, Lee KY, Ma SH, Park JS, Kim HM, Kim CS, Kim DH, Choi YY, Cha SH, Hong YJ, Kang JH. Han SB, et al. Among authors: cha sh. Hum Vaccin Immunother. 2015;11(5):1094-102. doi: 10.1080/21645515.2015.1017693. Hum Vaccin Immunother. 2015. PMID: 25875868 Free PMC article. Clinical Trial.
Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea.
Kim DS, Jang GC, Cha SH, Choi SH, Kim HM, Kim JH, Kang JH, Kim JH, Kim KH, Bang J, Naimi Z, Bouckenooghe A, Bosch-Castells V, Houillon G. Kim DS, et al. Among authors: cha sh. Pediatr Infect Dis J. 2016 Feb;35(2):e60-4. doi: 10.1097/INF.0000000000000967. Pediatr Infect Dis J. 2016. PMID: 26535878 Clinical Trial.
Safety and immunogenicity of a single dose of a quadrivalent meningococcal conjugate vaccine (MenACYW-D): a multicenter, blind-observer, randomized, phase III clinical trial in the Republic of Korea.
Kim DS, Kim MJ, Cha SH, Kim HM, Kim JH, Kim KN, Lee JS, Choi JY, Castells VB, Kim HS, Bang J, Oster P. Kim DS, et al. Among authors: cha sh. Int J Infect Dis. 2016 Apr;45:59-64. doi: 10.1016/j.ijid.2016.02.010. Epub 2016 Feb 24. Int J Infect Dis. 2016. PMID: 26921548 Free article. Clinical Trial.
Immunogenicity and safety of the quadrivalent meningococcal vaccine MenACWY-TT co-administered with a combined diphtheria-tetanus-acellular pertussis vaccine versus their separate administration in adolescents and young adults: A phase III, randomized study.
Rivera L, Schwarz TF, Kim KH, Kim YK, Behre U, Cha SH, Jo DS, Lee J, Lee JS, Cheuvart B, Jastorff A, Van der Wielen M. Rivera L, et al. Among authors: cha sh. Vaccine. 2018 Jul 25;36(31):4750-4758. doi: 10.1016/j.vaccine.2018.04.034. Epub 2018 Jun 28. Vaccine. 2018. PMID: 29960800 Free article. Clinical Trial.
Response to primary and booster vaccination with 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine in Korean infants.
Kim CH, Kim JS, Cha SH, Kim KN, Kim JD, Lee KY, Kim HM, Kim JH, Hyuk S, Hong JY, Park SE, Kim YK, Kim NH, Fanic A, Borys D, Ruiz-Guiñazù J, Moreira M, Schuerman L, Kim KH. Kim CH, et al. Among authors: cha sh. Pediatr Infect Dis J. 2011 Dec;30(12):e235-43. doi: 10.1097/INF.0b013e31822a8541. Pediatr Infect Dis J. 2011. PMID: 21817957 Clinical Trial.
Early Changes in the Serotype Distribution of Invasive Pneumococcal Isolates from Children after the Introduction of Extended-valent Pneumococcal Conjugate Vaccines in Korea, 2011-2013.
Cho EY, Choi EH, Kang JH, Kim KH, Kim DS, Kim YJ, Ahn YM, Eun BW, Oh SH, Cha SH, Cho HK, Hong YJ, Kim KN, Kim NH, Kim YK, Kim JH, Lee H, Lee T, Kim HM, Lee KS, Kim CS, Park SE, Kim YM, Oh CE, Ma SH, Jo DS, Choi YY, Lee J, Bae GR, Park O, Park YJ, Kim ES, Lee HJ. Cho EY, et al. Among authors: cha sh. J Korean Med Sci. 2016 Jul;31(7):1082-8. doi: 10.3346/jkms.2016.31.7.1082. Epub 2016 Apr 27. J Korean Med Sci. 2016. PMID: 27366006 Free PMC article.
598 results